Opinion
Video
Author(s):
Robert Zalewski-Zaragoza, MD expands on the option of esketamine for treatment resistant depression, highlighting the unique mechanism of action and application.
SPN-820 Fails Phase 2b Trial for Treatment-Resistant Depression
Medical Ethics Unpacked: GLP-1 Allocation and Challenges of Equitable Access
Antidepressant Use Drops During Pregnancy Without Psychotherapy Increase
Medical Ethics Unpacked: Ethical Considerations for Euthanasia & Medical Assistance in Dying
Researchers Track Sharp Increase in Diagnoses for Sedative, Hypnotic and Anxiety Use Disorder in Young Adults
Children Who Experience a Stroke Have a Greater Anxiety Risk